Cognetivity Neurosciences Stock Today
| CGNSF Stock | USD 0 0 60.00% |
PerformanceGood
| Odds Of DistressHigh
|
Cognetivity Neurosciences is trading at 0.002 as of the 23rd of March 2025. This is a 60 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.002. Cognetivity Neurosciences has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.. The company has 85.05 M outstanding shares. More on Cognetivity Neurosciences
Moving against Cognetivity Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cognetivity Pink Sheet Highlights
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
Cognetivity Neurosciences [CGNSF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cognetivity Neurosciences's market, we take the total number of its shares issued and multiply it by Cognetivity Neurosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cognetivity Neurosciences classifies itself under Healthcare sector and is part of Health Information Services industry. The entity has 85.05 M outstanding shares.
Cognetivity Neurosciences has accumulated about 61.23 K in cash with (3.21 M) of positive cash flow from operations.
Check Cognetivity Neurosciences Probability Of Bankruptcy
Ownership AllocationCognetivity Neurosciences holds a total of 85.05 Million outstanding shares. Cognetivity Neurosciences shows 14.69 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cognetivity Ownership Details
Cognetivity Neurosciences Risk Profiles
| Mean Deviation | 24.46 | |||
| Semi Deviation | 21.81 | |||
| Standard Deviation | 41.27 | |||
| Variance | 1702.89 |
Cognetivity Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cognetivity Neurosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Cognetivity Neurosciences Corporate Management
| BA BA | Legal Director | Profile | |
| Jonathan ElSharkawy | Chief Officer | Profile | |
| Sina Habibi | CEO CoFounder | Profile | |
| SeyedMahdi KhalighRazavi | CoFounder Officer | Profile | |
| Thomas MBA | CFO, COO | Profile | |
| Christos Kalafatis | Chief Director | Profile |
Other Information on Investing in Cognetivity Pink Sheet
Cognetivity Neurosciences financial ratios help investors to determine whether Cognetivity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cognetivity with respect to the benefits of owning Cognetivity Neurosciences security.